Melika Marani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Melika Marani has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
- Shawn G. Kwatra
Department of Dermatology, University of Maryland School of Medicine, Baltimore, USA
7 shared publications - Madan M. Kwatra
Department of Anesthesiology, Duke University School of Medicine, Durham, North Carolina, USA
6 shared publications - Zachary A. Bordeaux
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
6 shared publications - Hannah Cornman
Department of Dermatology, University of Maryland School of Medicine, Baltimore, Maryland, USA
5 shared publications - Kevin K. Lee
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
5 shared publications - Junwen Deng
Department of Dermatology, Johns Hopkins University School of Medicine, Baltimore, MD
4 shared publications
Latest Publications
- 4 March 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (9) , 2085-2089.e1
Excoriation Disorder Is Characterized by Systemic Glutamatergic Dysfunction
- 4 March 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (9) , 2085-2089.e1
Excoriation Disorder Is Characterized by Systemic Glutamatergic Dysfunction
- Top Cited PapersOpen Access
- 19 January 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (7) , 1568-1578.e5
Single-Cell RNA Sequencing Reveals Dysregulated POSTN+WNT5A+ Fibroblast Subclusters in Prurigo Nodularis
- 19 January 2024
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (7) , 1568-1578.e5
Top Cited PapersOpen AccessSingle-Cell RNA Sequencing Reveals Dysregulated POSTN+WNT5A+ Fibroblast Subclusters in Prurigo Nodularis
- 26 May 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (12) , 2416-2426.e1
A Polygenic Risk Score for Predicting Racial and Genetic Susceptibility to Prurigo Nodularis
- 26 May 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (12) , 2416-2426.e1
A Polygenic Risk Score for Predicting Racial and Genetic Susceptibility to Prurigo Nodularis
- Open Access
- 5 May 2023
- Published by Elsevier in JID Innovations
- Vol. 3 (4) , 100206
Topical GZ21T Inhibits the Growth of Actinic Keratoses in a UVB-Induced Model of Skin Carcinogenesis
- 5 May 2023
- Published by Elsevier in JID Innovations
- Vol. 3 (4) , 100206
Open AccessTopical GZ21T Inhibits the Growth of Actinic Keratoses in a UVB-Induced Model of Skin Carcinogenesis
- 1 October 2022
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 187 (4) , 608-609
Association between prurigo nodularis and substance use disorders
- 1 October 2022
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 187 (4) , 608-609
Association between prurigo nodularis and substance use disorders
- Open Access
Topical GZ21T inhibits the growth of actinic keratoses in a UVB induced model of skin carcinogenesis
Actinic keratoses (AKs) are premalignant intraepidermal neoplasms that occur as a result of cumulative sun damage. AKs commonly relapse, and up to 16% undergo malignant transformation into cutaneous squamous cell carcinoma (cSCC). There is a need for novel therapies that reduce the quantity and surface area of AKs as well as prevent malignant transformation to cSCCs. We recently showed that GZ17-6.02, an anti-cancer agent composed of curcumin, haramine, and isovanillin, inhibited the growth of H297.T cells. The present study evaluated the efficacy of a novel topical formulation of GZ17-6.02, known as GZ21T, in a murine model of AK generated by exposing SKH1 mice to ultraviolet irradiation. Treatment of mice with topical GZ21T inhibited the growth of AKs by decreasing both lesion count ( p =.028) and surface area occupied by tumor ( p =.026). GZ21T also suppressed the progression of AKs to cSCC by decreasing the count ( p =.047) and surface area ( p =.049) of lesions more likely to represent cSCC. RNA sequencing and proteomic analyses revealed that GZ21T suppressed several pathways, including MAPK ( p =.026), Pi3K-Akt ( p =.028), HIF-1α ( p =.030), Wnt ( p =.031), insulin ( p =.011), and ErbB ( p =.006) signaling. GZ21T also upregulated the autophagy-promoting protein AMPK, while suppressing proteins such as PD-L1, glutaminase, pAkt1 S473, and eEF2K. GRAPHICAL
Open AccessTopical GZ21T inhibits the growth of actinic keratoses in a UVB induced model of skin carcinogenesis
Actinic keratoses (AKs) are premalignant intraepidermal neoplasms that occur as a result of cumulative sun damage. AKs commonly relapse, and up to 16% undergo malignant transformation into cutaneous squamous cell carcinoma (cSCC). There is a need for novel therapies that reduce the quantity and surface area of AKs as well as prevent malignant transformation to cSCCs. We recently showed that GZ17-6.02, an anti-cancer agent composed of curcumin, haramine, and isovanillin, inhibited the growth of H297.T cells. The present study evaluated the efficacy of a novel topical formulation of GZ17-6.02, known as GZ21T, in a murine model of AK generated by exposing SKH1 mice to ultraviolet irradiation. Treatment of mice with topical GZ21T inhibited the growth of AKs by decreasing both lesion count ( p =.028) and surface area occupied by tumor ( p =.026). GZ21T also suppressed the progression of AKs to cSCC by decreasing the count ( p =.047) and surface area ( p =.049) of lesions more likely to represent cSCC. RNA sequencing and proteomic analyses revealed that GZ21T suppressed several pathways, including MAPK ( p =.026), Pi3K-Akt ( p =.028), HIF-1α ( p =.030), Wnt ( p =.031), insulin ( p =.011), and ErbB ( p =.006) signaling. GZ21T also upregulated the autophagy-promoting protein AMPK, while suppressing proteins such as PD-L1, glutaminase, pAkt1 S473, and eEF2K. GRAPHICAL
- 27 October 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (5) , 1300-1308.e3
Cluster Analysis of Circulating Plasma Biomarkers in Prurigo Nodularis Reveals a Distinct Systemic Inflammatory Signature in African Americans
- 27 October 2021
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (5) , 1300-1308.e3
Cluster Analysis of Circulating Plasma Biomarkers in Prurigo Nodularis Reveals a Distinct Systemic Inflammatory Signature in African Americans